
Lisa Subeck: Medicare needs to reverse unprecedented decision and make Alzeheimer’s treatment accessible
CMS must reconsider its national coverage determination for Coverage with Evidence Development so patients can have access to the care they need if it is determined to be a good fit for their health.
























